We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Mitchell J. Lazris

Partner
Washington, D.C.

Mitchell J. Lazris

Mitch Lazris focuses on complex enforcement investigations in the life sciences industry and litigation relating to a range of healthcare issues. He is a member of the firm's Life Science Industry Sector team and the firm's White Collar and Fraud Steering Committee.

For over 15 years, Mitch has represented pharmaceutical companies, medical device companies, academic health centers, physician practices, and insurers in a wide variety of government investigations, both civil and criminal, involving issues arising under federal and state laws. He has defended clients from disputes arising under the Anti-Kickback Act; the Food, Drug, and Cosmetic Act; the False Claims Act; and state consumer protection acts. His experience encompasses internal investigations, congressional investigations, grand jury practice, as well as related civil litigation activity, such as the defense of qui tam litigation under the False Claims Act and related laws.

Prior to joining Hogan Lovells, Mitch was a trial attorney in the Civil Fraud Section of the Department of Justice. In that capacity, he investigated, litigated, and settled complex multimillion dollar civil False Claims Act matters, including numerous qui tam actions. His primary areas of focus were healthcare and defense contract fraud matters, which often involved parallel criminal and state investigations.

Representative Experience

Representing medical device companies in connection with numerous federal investigations of sales and marketing and FDCA promotional issues.

Secured DOJ criminal and civil declinations in investigations of pharmaceutical, biologics, and medical device companies in connection with allegations of sales, marketing, and pricing misconduct.

Won numerous motions to dismiss for pharmaceutical and biologics companies in declined False Claims Act qui tam lawsuits alleging sales, marketing, and pricing misconduct.

Secured DOJ declination in civil investigation of healthcare insurer for alleged misconduct in connection with its Medicare Part D bid.

Secured favorable civil DOJ settlement in connection with a wide ranging criminal and civil investigation of global pharmaceutical company's sales, marketing, and pricing tactics.

Represented pharmaceutical, biologics, and medical defense companies in connection with Congressional investigations.

Secured favorable civil DOJ settlement in connection with investigation of government contractor for allegedly providing sub-standard product.

Education and admissions

Education

  • J.D., cum laude, Harvard Law School, 1992
  • A.B., magna cum laude, Princeton University, 1988

Bar admissions and qualifications

  • District of Columbia
  • Virginia

Court admissions

  • U.S. District Court, District of Columbia
  • U.S. District Court, District of Maryland
  • U.S. District Court, Eastern District of Virginia

Latest thinking and events

View More
Loading data